Western blot analysis displayed that CEA expression was not affected by onalespib treatment in any of the assessed colorectal cancer cell lines, while known HSP90-related markers, such as EGFR and AKT1,2,3, displayed alterations. Here, CEACAM5 is linked to colorectal cancer.